Skip to content

Author

Roberta Rovito

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Beyond seropositivity: SARS-CoV-2 IgG responses in high-risk COVID-19 patients.

Findings highlight variant-specific limitations of anti-Spike IgG as a universal marker of protection and support the need for integrated serological and virological assessment to guide antiviral and monoclonal antibody strategies in vulnerable populations.

Matteo Domenico Marsiglia, Roberta Rovito, A. Amendola et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.